This website serves as a source of news and information for the residents of Bridgewater, Bound Brook, and surrounding communities regarding the remedy and restoration of the American Cyanamid Superfund Site owned by Wyeth Holdings LLC (WH). Pfizer Inc assumed responsibility for the site on October 15, 2009, through its larger acquisition of Wyeth. Although Pfizer never operated at the site, Pfizer takes its responsibility seriously and is aggressively working to improve site conditions.
Under the oversight of the U.S. Environmental Protection Agency (USEPA) and the New Jersey Department of Environmental Protection (NJDEP), Pfizer is working to accomplish four key objectives:
- To implement a remediation program that is protective of human health and the environment;
- To ensure that site remediation activities facilitate reuse and redevelopment of portions of the property;
- To preserve and enhance the ecological assets of the property in a manner that creates value in the Raritan River regional ecosystem; and
- To position the property as an asset to the local community and the region.
The United States, on behalf of the U.S. Environmental Protection Agency (USEPA), and Wyeth Holdings LLC (WH), formerly known as American Cyanamid Company and the current owner of the American Cyanamid Superfund Site, have reached a formal agreement to proceed with implementation of the site-wide remedy at the American Cyanamid Superfund Site.
Under this agreement, WH will move forward with the implementation of the remedy of site soils, site groundwater, and a majority of the remaining impoundments still requiring remediation, as described in the Record of Decision issued by USEPA on September 27, 2012. This Consent Decree is an important step that allows WH to continue moving forward with efforts to address impacts from past industrial operations on the site.
USEPA and WH previously executed an Administrative Settlement Agreement and Order on Consent to move forward with remedial design for the Site-wide Remedy. The WH team has invested significant resources in the engineering and design of this remediation program. This Consent Decree allows for the implementation of the remediation activities, as approved by USEPA.
In addition, WH is proceeding with the Focused Feasibility Study (FFS) for USEPA Operable Unit 8 (OU8), commonly referred to as Impoundments 1 and 2, the only Operable Unit that still requires USEPA to issue a Record of Decision for a remedy. To learn more about the FFS, visit the OU8 FFS page.
Pfizer continues to actively work with USEPA, NJDEP, and other stakeholders, to move the site remediation process forward. We are committed to implementing a site restoration program that is responsive to stakeholder input and returns the property to productive use. Additional details regarding the status of the site and recent activities can be found on the Site Progress page.